Sources: Shanghai-based Anew Labs, a ByteDance spinoff using AI for drug discovery, raised $290M from HSG, IDG Capital, and others at a $1.5B valuation (Kane Wu/Reuters)
This story is from 2026-09-16. It is preserved in the archive; the latest stories are on the live feed.
Kane Wu / Reuters : Sources: Shanghai-based Anew Labs, a ByteDance spinoff using AI for drug discovery, raised $290M from HSG, IDG Capital, and others at a $1.5B valuation Chinese social media and internet company ByteDance has completed a $290 million fundraising for its AI drugmaking unit after s…
Read the full story at Techmeme ↗
Timeline · 2 reports
- 2026-09-16 08:10 · The Next Web
ByteDance’s AI drug unit Anew Labs raises $290M at $1.5B valuation, Reuters reports - 2026-09-16 06:30 · Techmeme
Sources: Shanghai-based Anew Labs, a ByteDance spinoff using AI for drug discovery, raised $290M from HSG, IDG Capital, and others at a $1.5B valuation (Kane Wu/Reuters)